Please login to the form below

Not currently logged in
Email:
Password:

pancrelipase

This page shows the latest pancrelipase news and features for those working in and with pharma, biotech and healthcare.

Allergan eyes early 2017 European launch for Enzepi

Allergan eyes early 2017 European launch for Enzepi

Allergan's Enzepi (pancrelipase) has been recommended for European approval to treat exocrine pancreatic insufficiency (EPI) in patients with conditions such as cystic fibrosis.

Latest news

  • AbbVie sales jump on strong Humira gains AbbVie sales jump on strong Humira gains

    Pancreatic enzyme replacement therapy Creon (pancrelipase) grew 20 per cent to $106m while Zemplar (paricalcitol) for hyperparathyroidism was up 12.5 per cent to $63m, reversing first -quarter declines as AbbVie

  • AbbVie expects Humira to drive growth in inaugural guidance AbbVie expects Humira to drive growth in inaugural guidance

    Top of the list in the speciality division is testosterone replacement therapy AndroGel – 31 per cent to $1.15bn in 2012 – with support from Creon (pancrelipase) for pancreatic insufficiency and hypothyroidism

  • Abbott wins FDA approval for infant CF dose

    Abbott wins FDA approval for infant CF dose. Abbott has secured approval for an infant-specific dose of CREON (pancrelipase) to treat exocrine pancreatic insufficiency caused by cystic fibrosis (CF). ... Abbott has secured Food and Drug Administration

  • Breathing easier

    Canada . Pancrelipase . Zenpep (Eurand). Pancreatic disorders . US. Telmisartan/amlodipine. Twynsta (Boehringer Ingelheim).

  • J&J's enzyme treatment approved

    The US Food and Drug Administration (FDA) has announced the approval of Pancreaze (pancrelipase), Johnson &Johnson's (J&J) pancreatic enzyme product (PEP) available as a delayed release capsule. ... This is the third approval for a PEP by the FDA since

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics